Cite
HARVARD Citation
Anastasilakis, A. et al. (n.d.). Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment. Expert opinion on therapeutic targets. pp. 299-306. [Online].